ATOSSA HEALTHCARE INC has a total of 18 patent applications. Its first patent ever was published in 1997. It filed its patents most often in United States, Australia and WIPO (World Intellectual Property Organization). Its main competitors in its focus markets medical technology, pharmaceuticals and biotechnology are HOPE NAT MEDICAL CENTER, FIRST AFFILIATED HOSPITAL SOOCHOW UNIV and TDL INNOVATIONS LLC.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 7 | |
#2 | Australia | 3 | |
#3 | WIPO (World Intellectual Property Organization) | 3 | |
#4 | Canada | 2 | |
#5 | EPO (European Patent Office) | 2 | |
#6 | Japan | 1 |
# | Industry | |
---|---|---|
#1 | Medical technology | |
#2 | Pharmaceuticals | |
#3 | Biotechnology | |
#4 | Machines | |
#5 | Measurement | |
#6 | Computer technology | |
#7 | Control |
# | Name | Total Patents |
---|---|---|
#1 | Quay Steven C | 18 |
#2 | Quay Debra L | 3 |
#3 | Sestak Joshua O | 1 |
#4 | Quay Debra | 1 |
#5 | Costantino Henry R | 1 |
#6 | Leonard Alexis K | 1 |
#7 | Sileno Anthony P | 1 |
Publication | Filing date | Title |
---|---|---|
US2007032410A1 | Compositions and methods for the treatment of psychiatric disorders | |
WO0238032A2 | Methods and devices for collecting and processing mammary fluid | |
WO0230451A1 | Compositions and methods for reducing gnrh-induced bone loss | |
AU7916801A | Bimodal emulsions of taxanes and butyrate polyalcohol esters | |
US6894026B1 | Long-acting oxytocin analogues for the treatment and prevention of breast cancer and psychiatric disorders |